UNCY
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Unicycive Therapeutics' Oxylanthanum Carbonate NDA resubmission accepted by FDAJan 30, 2026
- Unicycive resubmits NDA for oxylanthanum carbonate (OLC)Dec 29, 2025
- Unicycive Therapeutics granted new U.S. patent for UNI-494 to treat chronic kidney diseaseAug 18, 2025
- Unicycive provides update on NDA for Oxylanthanum Carbonate for dialysis-related hyperphosphatemiaJun 10, 2025